Robert A. Lipper
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
-
- Biochemical and Molecular Research 2
- Protein purification and stability 1
- Cancer therapeutics and mechanisms 1
-
- Drug Solubulity and Delivery Systems 3
- Co-authors
- W.I. Higuchi (1 shared paper)Vinod P. Shah (2 shared papers)D.M. Barends (1 shared paper)E Gupta (1 shared paper)Kimberley A. Lentz (1 shared paper)Ankie M. Harmsze (1 shared paper)Jennifer Dressman (1 shared paper)Bertil Abrahamsson (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Journal of Crohn s and Colitis (1 paper)Molecular Pharmacology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)The AAPS Journal (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Robert A. Lipper
8 papers receiving 299 citations
Peers
Comparison fields: 5 of 66
- Pharmaceutical Science 136
- Filtration and Separation 11
- Pharmacology 43
- Analytical Chemistry 40
- Computational Theory and Mathematics 57
Countries citing papers authored by Robert A. Lipper
This map shows the geographic impact of Robert A. Lipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Lipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Lipper more than expected).
Fields of papers citing papers by Robert A. Lipper
This network shows the impact of papers produced by Robert A. Lipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Lipper. The network helps show where Robert A. Lipper may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Lipper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 175 | |
| 2 | 2006 | 53 | |
| 3 | 2008 | 47 | |
| 4 | 1977 | 37 | |
| 5 | Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase. | 1978 | 9 |
| 6 | 1986 | 3 | |
| 7 | 1978 | 2 | |
| 8 | 2025 | 1 |
About Robert A. Lipper
Robert A. Lipper is a scholar working on Molecular Biology, Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Organic Chemistry and Surgery, having authored 8 papers that have together received 327 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Biochemical and Molecular Research (2 papers), Pharmaceutical studies and practices (2 papers), Folate and B Vitamins Research (1 paper), Protein purification and stability (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Adenosine and Purinergic Signaling (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Pharmaceutical Science (136 citations), Filtration and Separation (11 citations), Pharmacology (43 citations), Analytical Chemistry (40 citations) and Computational Theory and Mathematics (57 citations). Robert A. Lipper has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include W.I. Higuchi, Vinod P. Shah, D.M. Barends, E Gupta, Kimberley A. Lentz, Ankie M. Harmsze, Jennifer Dressman, Bertil Abrahamsson, Lawrence X. Yu and Paul Fackler. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Crohn s and Colitis, Molecular Pharmacology, European Journal of Pharmaceutical Sciences and The AAPS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.